Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hollinger

Showing results (671-680 of 880) with videos related to

Pageof 88
Sort By:
Annals of Internal Medicine|September 1, 1979
Etiology of liver disease in renal-transplant patientsA J Ware, J P Luby, B Hollinger, et al.
The Journal of Infectious Diseases|April 1, 1994
Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology LaboratoriesV DeGruttola, L A Beckett, R W Coombs, et al.
The Review of Scientific Instruments|March 1, 2023
Compact high repetition rate Thomson parabola ion spectrometerR Nedbailo, J Park, R Hollinger, et al.
Brain, Behavior, & Immunity - Health|June 23, 2022
Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected miceBenjamin J Bell, Kristen R Hollinger, Pragney Deme, et al.
Journal of Virology|May 1, 1983
Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptideR C Kennedy, G R Dreesman, J T Sparrow, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 27, 2007
Bilateral sequential lung and simultaneous pancreas transplant: a new approach for the recipient with cystic fibrosisJonathan A Fridell, Thomas C Wozniak, John M Reynolds, et al.
Acta Biomaterialia|March 31, 2009
End-group effects on the properties of PEG-co-PGA hydrogelsSidi A Bencherif, Abiraman Srinivasan, Jeffrey A Sheehan, et al.
Cells|April 3, 2020
Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase ComplexMarissa M Minor, F Blaine Hollinger, Adrienne L McNees, et al.
Drug Discovery Today|April 2, 2021
Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseasesCarolyn Tallon, Kristen R Hollinger, Arindom Pal, et al.
Pacing and Clinical Electrophysiology : PACE|January 1, 1993
Initial experience with transvenous implantable cardioverter defibrillator lead systems: operative morbidity and mortalityR Frame, R Brodman, J Gross, et al.
Pageof 88

Showing results (671-680 of 880) with videos related to

Sort By:
Pageof 88
Annals of Internal Medicine|September 1, 1979
Etiology of liver disease in renal-transplant patientsA J Ware, J P Luby, B Hollinger, et al.
The Journal of Infectious Diseases|April 1, 1994
Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology LaboratoriesV DeGruttola, L A Beckett, R W Coombs, et al.
The Review of Scientific Instruments|March 1, 2023
Compact high repetition rate Thomson parabola ion spectrometerR Nedbailo, J Park, R Hollinger, et al.
Brain, Behavior, & Immunity - Health|June 23, 2022
Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected miceBenjamin J Bell, Kristen R Hollinger, Pragney Deme, et al.
Journal of Virology|May 1, 1983
Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptideR C Kennedy, G R Dreesman, J T Sparrow, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 27, 2007
Bilateral sequential lung and simultaneous pancreas transplant: a new approach for the recipient with cystic fibrosisJonathan A Fridell, Thomas C Wozniak, John M Reynolds, et al.
Acta Biomaterialia|March 31, 2009
End-group effects on the properties of PEG-co-PGA hydrogelsSidi A Bencherif, Abiraman Srinivasan, Jeffrey A Sheehan, et al.
Cells|April 3, 2020
Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase ComplexMarissa M Minor, F Blaine Hollinger, Adrienne L McNees, et al.
Drug Discovery Today|April 2, 2021
Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseasesCarolyn Tallon, Kristen R Hollinger, Arindom Pal, et al.
Pacing and Clinical Electrophysiology : PACE|January 1, 1993
Initial experience with transvenous implantable cardioverter defibrillator lead systems: operative morbidity and mortalityR Frame, R Brodman, J Gross, et al.
Pageof 88